Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Cryo-Touch III Refinement Study Investigational Plan
Authors not listed
Pacira Pharmaceuticals, Inc · 2011
Abstract
This is a prospective, non-randomized study to evaluate the performance of the MyoScience Cryo-Touch III device for the treatment of glabellar and/or forehead wrinkles.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
Anonymous. (2011). Cryo-Touch III Refinement Study Investigational Plan. <em>Pacira Pharmaceuticals, Inc</em>. https://clinicaltrials.gov/study/NCT01379365
Vancouver
Anonymous. Cryo-Touch III Refinement Study Investigational Plan. Pacira Pharmaceuticals, Inc. 2011.
BibTeX
@misc{anon2011CryoTo,
title = {Cryo-Touch III Refinement Study Investigational Plan},
author = {Anonymous},
journal = {Pacira Pharmaceuticals, Inc},
year = {2011},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Lymphoma Academic Research Organisation 2009
Open access · US-GOV
Double Blind Randomized Phase III Study of Lenalidomide Maintenance Versus Placebo in Responding Elderly Patients With DLBCL and Treated With R-CHOP in First Line
Osteoporosis International 2013
Citation only
Frailty and osteoporosis in older women—a prospective study
Laserklinik Karlsruhe 2005
Open access · US-GOV
A Comparative Randomized Double-Blinded Study of the Effect of Dysport and Botox on Forehead Wrinkles and EMG Activity
University of Leeds 2020
Open access · US-GOV
Myeloma XIV: A Phase III Trial to Compare Standard and Frailty-adjusted Induction Therapy With Ixazomib, Lenalidomide and Dexamethasone (IRD) and Maintenance Lenalidomide (R) to Lenalidomide Plus Ixazomib (R+I)
Organon and Co 2001
Open access · US-GOV
A Multi-center, Double-Blind, Randomized, Parallel Group Study to Evaluate the Effects of Two Different Doses of Losartan on Morbidity and Mortality in Patients With Symptomatic Heart Failure Intolerant of ACE Inhibitor Treatment
Istituto Oncologico Veneto IRCCS 2019
Open access · US-GOV